文献速递妇科母胎医学

BRCA质量改进推广计划在五家医疗系统提高癌症遗传学服务接受率的结果

Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
PubMed 文献 · Gynecol Oncol · 2023-03-31

该质量改进项目在五家社区肿瘤诊疗中心开展,旨在提高卵巢癌和三阴性乳腺癌患者的转诊、遗传咨询及胚系基因检测率。比较项目开展前2年与项目期间确诊患者的病历,卵巢癌患者转诊率由70%升至79%、遗传咨询由44%升至61%、基因检测由54%升至62%,三阴性乳腺癌患者亦见上升。

要点

  • 卵巢癌患者转诊率从70%升至79%,遗传咨询从44%升至61%,基因检测从54%升至62%。
  • 三阴性乳腺癌患者转诊率从90%升至92%,遗传咨询从68%升至72%,基因检测从81%升至86%。
  • 有效干预包括简化遗传咨询预约流程和标准化转诊流程。

核心结论

  • 为期多年的质量改进项目在五家独特的社区肿瘤诊疗环境中提高了患者转诊率和推荐遗传学服务的接受率。

研究设计与样本

  • 质量改进项目在五家社区医疗系统的肿瘤诊疗中心开展,各中心活动持续数年,均于2020年12月前结束。
  • 回顾项目开展前2年与项目期间确诊的卵巢癌和三阴性乳腺癌患者病历,比较转诊、遗传咨询和基因检测率。
  • 采用描述性统计、两样本t检验、卡方检验或Fisher精确检验以及逻辑回归分析结局。

主要发现

  • 卵巢癌患者转诊率从70%升至79%,遗传咨询从44%升至61%,基因检测从54%升至62%,从诊断到遗传咨询和基因检测的时间缩短。
  • 三阴性乳腺癌患者转诊率从90%升至92%,遗传咨询从68%升至72%,基因检测从81%升至86%。
  • 有效干预简化了遗传咨询预约流程并标准化了转诊流程。

关键数值与推荐

  • 卵巢癌患者转诊率70%升至79%、遗传咨询44%升至61%、基因检测54%升至62%。
  • 三阴性乳腺癌患者转诊率90%升至92%、遗传咨询68%升至72%、基因检测81%升至86%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A quality improvement initiative (QII) was conducted with five community-based health systems' oncology care centers (sites A-E). The QII aimed to increase referrals, genetic counseling (GC), and germline genetic testing (GT) for patients with ovarian cancer (OC) and triple-negative breast cancer (TNBC). METHODS: QII activities occurred at sites over several years, all concluding by December 2020. Medical records of patients with OC and TNBC were reviewed, and rates of referral, GC, and GT of patients diagnosed during the 2 years before the QII were compared to those diagnosed during the QII. Outcomes were analyzed using descriptive statistics, two-sample t-test, chi-squared/Fisher's exact test, and logistic regression. RESULTS: For patients with OC, improvement was observed in the rate of referral (from 70% to 79%), GC (from 44% to 61%), GT (from 54% to 62%) and decreased time from diagnosis to GC and GT. For patients with TNBC, increased rates of referral (from 90% to 92%), GC (from 68% to 72%) and GT (81% to 86%) were observed. Effective interventions streamlined GC scheduling and standardized referral processes. CONCLUSION: A multi-year QII increased patient referral and uptake of recommended genetics services across five unique community-based oncology care settings.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bednar EM, Chen M, Walsh MT, et al. Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems. Gynecol Oncol. 2023. PMID: 37004303. doi:10.1016/j.ygyno.2023.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。